JONEA LIM
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism OKLAHOMA CITY, OK NPI 1285774331
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism OK Novo Nordisk AS All categories
General Payments — all program years on this page
$768.68
- Category: General Payments
- Program years: PY2018–2023
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $389.29 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $225.89 | 7 |
| Food and Beverage | $163.40 | 2 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $225.89 | 7 |
| Medtronic, Inc. | $141.66 | 1 |
| Abbott Laboratories | $21.74 | 1 |
By program year
Records — PY2023 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1002105023 | Novo Nordisk Inc | $32.27 | 11/17/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1002105029 | Novo Nordisk Inc | $32.27 | 11/17/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1002105041 | Novo Nordisk Inc | $32.27 | 11/17/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1002105053 | Novo Nordisk Inc | $32.27 | 11/17/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1002105067 | Novo Nordisk Inc | $32.27 | 11/17/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1002105077 | Novo Nordisk Inc | $32.27 | 11/17/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1002105089 | Novo Nordisk Inc | $32.27 | 11/17/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1018857467 | Abbott Laboratories | $21.74 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1019436179 | Medtronic, Inc. | $141.66 | 12/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.